WuXi Biologics Congratulates Amicus Therapeutics on European

WUXI, China, March 28, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates its strategic

Related Keywords

Wuxi , Jiangsu , China , Singapore , Germany , United States , Ireland , Chris Chen , European Commission , Manufacturing Organization , Committee For Medicinal Products Human Use , Contract Research , Amicus Therapeutics , Wuxi Biologics , Wuxi Biologic , Medicinal Products , Human Use , Iologics , Ongratulates , Amicus , Herapeutics , European , Commission , Approval , Ombiliti , Patients , Gate , Onset , Pompe , Disease ,